LCTX Historical PE Ratio image   This LCTX PE ratio history page last updated 3/21/2024
LCTX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/7/2024
1.13-0.03-0.12NA
Q3 2023
11/9/2023
1.07-0.04-0.16NA
Q2 2023
8/10/2023
1.41-0.03-0.12NA
Q1 2023
5/11/2023
1.41-0.03-0.12NA
Q4 2022
3/9/2023
1.46-0.03-0.12NA
Q3 2022
11/10/2022
1.33-0.04-0.16NA
Q2 2022
8/11/2022
1.55-0.04-0.16NA
Q1 2022
5/12/2022
1.18-0.04-0.16NA
Q4 2021
3/10/2022
1.40-0.17-0.68NA
Q3 2021
11/10/2021
2.36-0.05-0.20NA
Q2 2021
8/12/2021
2.61-0.03-0.12NA
Q1 2021
5/13/2021
2.17-0.01-0.04NA
Q4 2020
3/11/2021
2.340.010.0458.5
Q3 2020
11/4/2020
1.21-0.05-0.20NA
Q2 2020
8/6/2020
0.92-0.04-0.16NA
Q1 2020
5/7/2020
0.96-0.06-0.24NA
Q4 2019
3/12/2020
0.68-0.03-0.12NA
Q3 2019
11/12/2019
0.72-0.11-0.44NA
Q2 2019
8/8/2019
0.99-0.20-0.80NA
Q1 2019
5/9/2019
1.180.301.201.0
Q4 2018
3/14/2019
1.55-0.36-1.44NA
Q3 2018
11/8/2018
1.990.532.120.9
Q2 2018
8/2/2018
2.37-0.03-0.12NA
Q1 2018
5/10/2018
2.21-0.50-2.00NA
Q4 2017
3/15/2018
2.54-0.58-2.32NA
Q3 2017
11/9/2017
2.25-0.08-0.32NA
Q2 2017
8/2/2017
2.57-0.11-0.44NA
Q1 2017
5/10/2017
3.05-0.08-0.32NA
Q4 2016
3/16/2017
3.10-0.05-0.20NA
Q3 2016
11/3/2016
2.89-0.09-0.36NA
Q2 2016
8/9/2016
3.28-0.11-0.44NA
Q1 2016
5/10/2016
2.88-0.19-0.76NA
Q4 2015
3/29/2016
2.67-0.13-0.52NA
Q3 2015
11/9/2015
3.55-0.18-0.72NA
Q2 2015
8/10/2015
2.92-0.12-0.48NA
Q1 2015
5/11/2015
5.18-0.13-0.52NA
Q4 2014
3/11/2015
4.13-0.14-0.56NA
Q3 2014
11/10/2014
3.44-0.12-0.48NA
Q2 2014
8/12/2014
2.86-0.16-0.64NA
Q1 2014
5/12/2014
2.60-0.14-0.56NA
Q4 2013
3/17/2014
3.57-0.35-1.40NA
Q3 2013
11/12/2013
3.74-0.16-0.64NA
Q2 2013
8/9/2013
3.71-0.14-0.56NA
Q1 2013
5/10/2013
4.08-0.15-0.60NA
Q4 2012
3/18/2013
4.34-0.12-0.48NA
LCTX PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/7/2024
1.13-0.03-0.13NA
Q3 2023
11/9/2023
1.07-0.04-0.13NA
Q2 2023
8/10/2023
1.41-0.03-0.13NA
Q1 2023
5/11/2023
1.41-0.03-0.14NA
Q4 2022
3/9/2023
1.46-0.03-0.15NA
Q3 2022
11/10/2022
1.33-0.04-0.29NA
Q2 2022
8/11/2022
1.55-0.04-0.30NA
Q1 2022
5/12/2022
1.18-0.04-0.29NA
Q4 2021
3/10/2022
1.40-0.17-0.26NA
Q3 2021
11/10/2021
2.36-0.05-0.08NA
Q2 2021
8/12/2021
2.61-0.03-0.08NA
Q1 2021
5/13/2021
2.17-0.01-0.09NA
Q4 2020
3/11/2021
2.340.01-0.14NA
Q3 2020
11/4/2020
1.21-0.05-0.18NA
Q2 2020
8/6/2020
0.92-0.04-0.24NA
Q1 2020
5/7/2020
0.96-0.06-0.40NA
Q4 2019
3/12/2020
0.68-0.03-0.04NA
Q3 2019
11/12/2019
0.72-0.11-0.37NA
Q2 2019
8/8/2019
0.99-0.200.273.7
Q1 2019
5/9/2019
1.180.300.442.7
Q4 2018
3/14/2019
1.55-0.36-0.36NA
Q3 2018
11/8/2018
1.990.53-0.58NA
Q2 2018
8/2/2018
2.37-0.03-1.19NA
Q1 2018
5/10/2018
2.21-0.50-1.27NA
Q4 2017
3/15/2018
2.54-0.58-0.85NA
Q3 2017
11/9/2017
2.25-0.08-0.32NA
Q2 2017
8/2/2017
2.57-0.11-0.33NA
Q1 2017
5/10/2017
3.05-0.08-0.33NA
Q4 2016
3/16/2017
3.10-0.05-0.44NA
Q3 2016
11/3/2016
2.89-0.09-0.52NA
Q2 2016
8/9/2016
3.28-0.11-0.61NA
Q1 2016
5/10/2016
2.88-0.19-0.62NA
Q4 2015
3/29/2016
2.67-0.13-0.56NA
Q3 2015
11/9/2015
3.55-0.18-0.57NA
Q2 2015
8/10/2015
2.92-0.12-0.51NA
Q1 2015
5/11/2015
5.18-0.13-0.55NA
Q4 2014
3/11/2015
4.13-0.14-0.56NA
Q3 2014
11/10/2014
3.44-0.12-0.77NA
Q2 2014
8/12/2014
2.86-0.16-0.81NA
Q1 2014
5/12/2014
2.60-0.14-0.79NA
Q4 2013
3/17/2014
3.57-0.35-0.80NA
Q3 2013
11/12/2013
3.74-0.16-0.57NA
Q2 2013
8/9/2013
3.71-0.14NANA
Q1 2013
5/10/2013
4.08-0.15NANA
Q4 2012
3/18/2013
4.34-0.12NANA
How should the LCTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Lineage Cell Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LCTX Historical PE Ratio page.

What is the average historical PE for LCTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LCTX historical PE ratio using the annualized quarterly earnings method works out to 20.1.

What is the average historical PE for LCTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LCTX historical PE ratio using the TTM earnings method works out to 3.2.

On this page we presented the LCTX Historical PE Ratio information for Lineage Cell Therapeutics' stock. The average LCTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 20.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LCTX historical PE based on this TTM earnings result method is 3.2. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LCTX historical PE result, against the recent PE: when this page was posted on 3/20/2024, the most recent closing price for LCTX had been 1.22, and the most recent quarterly earnings result, annualized, was 0.04. Meanwhile, the most recent TTM earnings summed to 0.27. From these numbers, we calculate the recent LCTX PE on 3/20/2024 based on annualized quarterly EPS was 30.5. Based on LCTX's history, that recent PE is elevated relative to the historical average, with the recent PE 51.7% higher than the historical average PE across our data set for Lineage Cell Therapeutics. Looking at the recent LCTX PE on 3/20/2024 based on TTM EPS, we calculate the ratio at 4.5. Based on LCTX's history, that recent PE is elevated relative to the historical average, with the recent PE 40.6% higher than the historical average PE across our Lineage Cell Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on LCTX or any other given stock, valuation analysis for LCTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Lineage Cell Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LCTX. Thanks for visiting, and the next time you need to research LCTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of WCN, MBIN shares outstanding history, IEX Technical Analysis.

 

LCTX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.